For the quarter ending 2026-03-31, TELA made $19,059K in revenue. -$12,279K in net income. Net profit margin of -64.43%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 19,059 | 20,869 | 20,689 | 20,197 |
| Cost of revenue (excluding amortization of intangible assets) | 6,444 | 7,019 | 6,625 | 5,997 |
| Amortization of intangible assets | 95 | 95 | 95 | 95 |
| Gross profit | 12,520 | 13,755 | 13,969 | 14,105 |
| Sales and marketing | 16,537 | 14,490 | 15,227 | 16,857 |
| General and administrative | 4,166 | 3,784 | 3,948 | 4,126 |
| Research and development | 2,343 | 2,129 | 2,348 | 2,203 |
| Total operating expenses | 23,046 | 20,403 | 21,523 | 23,186 |
| Loss from operations | -10,526 | -6,648 | -7,554 | -9,081 |
| Interest expense | 2,053 | 1,637 | 1,201 | 1,188 |
| Loss on extinguishment of debt | - | -888 | - | - |
| Other income | 366 | 277 | 152 | 379 |
| Total other expense, net | -1,687 | -2,248 | -1,049 | -809 |
| Loss before income tax expense | -12,213 | -8,896 | -8,603 | -9,890 |
| Income tax expense | 60 | 145 | - | 33 |
| Net loss | -12,273 | -9,041 | -8,603 | -9,923 |
| Foreign currency translation adjustment | -6 | 0 | -2 | 2 |
| Comprehensive loss | -12,279 | -9,041 | -8,605 | -9,921 |
| Basic EPS | -0.21 | -0.175 | -0.19 | -0.22 |
| Diluted EPS | -0.21 | -0.175 | -0.19 | -0.22 |
| Basic Average Shares | 57,256,518 | 51,737,588 | 45,421,795 | 45,365,325 |
| Diluted Average Shares | 57,256,518 | 51,737,588 | 45,421,795 | 45,365,325 |
TELA Bio, Inc. (TELA)
TELA Bio, Inc. (TELA)